Handheld Breath Analyzer for Rapid COVID-19 Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current COVID-19 diagnosis methods, particularly molecular tests, are invasive, time-consuming, and ineffective for asymptomatic carriers, leading to delayed detection and increased transmission due to their reliance on swab samples and laboratory procedures.
Innovation Solution
A non-invasive, handheld device using artificially intelligent hybrid sensor arrays with multiplexed detection capabilities to analyze volatile organic compounds (VOCs) in exhaled breath for rapid and accurate COVID-19 diagnosis, capable of detecting the virus before symptoms appear.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If molecular tests are used for COVID-19 diagnosis, then diagnostic accuracy is improved, but detection time is extended and operational complexity increases
Solution Approach 1:
The invention extracts the diagnostic function from centralized laboratories to point-of-care settings by implementing portable detection devices that can perform molecular testing locally, eliminating the need for sample transport and centralized processing while maintaining diagnostic accuracy
Solution Approach 2:
The patent replaces complex mechanical laboratory procedures with automated microfluidic systems and integrated electronic detection platforms, reducing manual operations and enabling rapid results within minutes without sacrificing measurement precision
2Reliability
If molecular tests with swab samples are used, then diagnostic reliability is improved, but ease of operation deteriorates
Solution Approach 1:
The invention merges sample collection, processing, and detection functions into a single integrated device, eliminating the need for separate swabbing, transport, and laboratory analysis steps, thereby maintaining reliability while dramatically improving ease of operation
Solution Approach 2:
The portable device performs multiple functions including sample collection, nucleic acid extraction, amplification, and detection in one unit, making the system universally applicable across different settings without requiring specialized laboratory infrastructure
3Measurement precision
If laboratory-based molecular testing is used, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The invention implements a nested architecture where microfluidic channels, reagent reservoirs, and detection components are integrated within a compact handheld device, maintaining laboratory-grade detection accuracy while reducing overall device complexity and portability requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables early detection of COVID-19 in asymptomatic individuals with high accuracy, reducing transmission and healthcare burden by providing rapid results and continuous monitoring, thereby supporting epidemic control and patient management.
Implementation Method 1
a sensor surface comprising one or more sensing regions, each of the sensing regions comprising ligand-coated nanoparticles, configured and operable for interacting with one or more VOCs present in the subject's exhaled breath
Data Source
AI summary
The invention proposes an approach utilizing novel and artificially intelligent hybrid sensor arrays with multiplexed detection capabilities for disease-specific biomarkers from the exhaled breath of a subject. The technology provides a rapid and highly accurate diagnosis in various COVID-19 infection and transmission scenarios.